Answers are grounded in this paper and cite their sources.
The Innovative Medicines Initiative Consortium RESOLUTE has started to develop tools and produce data sets to de-orphanize transporters in the solute carrier protein (SLC) superfamily, thereby lowering the barrier for the scientific community to explore SLCs as an attractive drug target class.
No takes yet. Share an insight, caveat, or question.
Superti‐Furga et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: